CIBC Private Wealth Group
IMGN

CIBC Private Wealth Group’s Immunogen Inc IMGN Stock Holding History

CIBC Private Wealth Group’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-315
Closed -$3K – 1802
2018
Q2 		$3K Buy
315
+164
+109% +$1.73K ﹤0.01% 1833
2018
Q1 		$2K Hold
151
– – ﹤0.01% 1824
2017
Q4 		$1K Buy
+151
New +$931 ﹤0.01% 1892

Other funds holding IMGN

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

CIBC Private Wealth Group's IMGN Position: Q3 2018 in Review

CIBC Private Wealth Group sold out of Immunogen Inc (IMGN) in Q3 2018, closing a stake of 315 shares — an estimated $3K sold.

CIBC Private Wealth Group first reported a position in IMGN in Q4 2017 and held it in 3 quarters. The position peaked at $3K in Q2 2018. 208 funds tracked by Wall St. Rank hold IMGN as of Q3 2018.

  • CIBC Private Wealth Group reported no remaining Immunogen Inc position as of Q3 2018 after selling out during the quarter.
  • CIBC Private Wealth Group sold 315 Immunogen Inc shares in Q3 2018, an estimated $3K.
  • CIBC Private Wealth Group first reported a position in Immunogen Inc in Q4 2017 and held it in 3 quarters.
  • CIBC Private Wealth Group's Immunogen Inc position peaked at $3K in Q2 2018.
  • 208 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2018.

Based on CIBC Private Wealth Group's 13F filing for Q3 2018, filed 14 Nov 2018.